Catalent
CTLT
#1585
Rank
NZ$17.59 B
Marketcap
$96.98
Share price
-0.18%
Change (1 day)
19.24%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Market cap: NZ$17.59 Billion

As of September 2024 Catalent has a market cap of NZ$17.59 Billion. This makes Catalent the world's 1585th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$17.59 B37.13%
2023NZ$12.83 B0.59%
2022NZ$12.75 B-61.87%
2021NZ$33.46 B40.41%
2020NZ$23.83 B95.05%
2019NZ$12.21 B80.59%
2018NZ$6.76 B-11.96%
2017NZ$7.68 B58.28%
2016NZ$4.85 B6.5%
2015NZ$4.55 B3.61%
2014NZ$4.40 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Catalent was reported to be:

NZ$17.59 Billion
by Yahoo Finance info icon info icon
NZ$17.59 Billion
by CompaniesMarketCap info icon info icon
NZ$17.58 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$2.83 B-83.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.21 B-93.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.05 B-37.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$1.28 B-92.70%๐Ÿ‡บ๐Ÿ‡ธ USA